Atticus Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $65.3K | Hold |
946
| – | – | 0.02% | 286 |
|
|
2025
Q1 | $65.7K | Hold |
946
| – | – | 0.02% | 207 |
|
|
2024
Q4 | $81.4K | Sell |
946
-919
| -49% | -$79.1K | 0.03% | 188 |
|
|
2024
Q3 | $222K | Sell |
1,865
-10
| -0.5% | -$1.19K | 0.07% | 113 |
|
|
2024
Q2 | $268K | Sell |
1,875
-12
| -0.6% | -$1.71K | 0.09% | 99 |
|
|
2024
Q1 | $242K | Sell |
1,887
-2,243
| -54% | -$288K | 0.08% | 114 |
|
|
2023
Q4 | $427K | Sell |
4,130
-774
| -16% | -$80.1K | 0.15% | 78 |
|
|
2023
Q3 | $446K | Buy |
4,904
+1,462
| +42% | +$133K | 0.17% | 78 |
|
|
2023
Q2 | $279K | Buy |
3,442
+2,546
| +284% | +$206K | 0.1% | 107 |
|
|
2023
Q1 | $71.3K | Hold |
896
| – | – | 0.03% | 209 |
|
|
2022
Q4 | $60.6K | Hold |
896
| – | – | 0.02% | 230 |
|
|
2022
Q3 | $50K | Hold |
896
| – | – | 0.02% | 230 |
|
|
2022
Q2 | $50K | Buy |
896
+788
| +730% | +$44K | 0.02% | 251 |
|
|
2022
Q1 | $6K | Buy |
+108
| New | +$6K | ﹤0.01% | 451 |
|